4investors | Börsen-News | Adhoc- und Unternehmensnews | Eckert & Ziegler

DGAP-News: Eckert & Ziegler will be admitted to the MSCI Germany Small Cap Index

Bild und Copyright: Eckert & Ziegler.

Bild und Copyright: Eckert & Ziegler.

14.05.2019 (www.4investors.de - in Kooperation mit DGAP - EQS Group):


DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous

Eckert & Ziegler will be admitted to the MSCI Germany Small Cap Index
14.05.2019 / 16:21


The issuer is solely responsible for the content of this announcement.
Berlin, 14 May 2019. Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry will be admitted to the MSCI Germany Small Cap Index as of 28 May 2019. This decision was announced by MSCI Inc., a leading provider of research-based indexes, after its semi-annual index review for the MSCI equity indexes. In addition to the high transparency requirements of the Prime Standard, the Eckert & Ziegler shares thereby also fulfill the relevant index criteria such as market capitalization, momentum and yield.

"The strong increase in the value of the share over the past few quarters has confirmed our strategy to focus Eckert & Ziegler more on innovative pharmaceuticals for cancer treatment",
explained Dr. Andreas Eckert, CEO of Eckert & Ziegler AG. "We are delighted by the admission to the MSCI Germany Small Cap Index which will further raise the interest in our share and extend our presence in the capital markets."

The MSCI Germany Small Cap Index currently is composed by 113 companies of the German equity market.About Eckert & Ziegler.
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with around 800 employees, is one of the world's largest providers of isotope-related components for radiation therapy and nuclear medicine.Contributing to saving lives.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com












14.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:
English
Company:
Eckert & Ziegler Strahlen- und Medizintechnik AG

Robert-Rössle-Str.10

13125 Berlin


Germany
Phone:
49 30 941084-138
Fax:
49 30 941084-112
E-mail:
karolin.riehle@ezag.de
Internet:
www.ezag.de
ISIN:
DE0005659700
WKN:
565970
Listed:
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:
811157

 
End of News
DGAP News Service




811157  14.05.2019 



Weitere DGAP-News von Eckert & Ziegler

30.08.2019 - DGAP-News: Eckert & Ziegler liefert Radioisotope an Alpha Tau
30.08.2019 - DGAP-News: Eckert & Ziegler fokussiert auf Radiopharmazeutika
27.08.2019 - DGAP-News: Eckert & Ziegler: zusätzliche Produktionskapazitäten für Gallium-68-Generatoren von Aufsichtsbehörden freigegeben
13.08.2019 - DGAP-News: Eckert & Ziegler wächst bei Umsatz und Erträgen
01.08.2019 - DGAP-News: Eckert & Ziegler bildet Joint Venture für Tumorbestrahlungsgeräte in China

4investors-News zu Eckert & Ziegler

18.09.2019 - Eckert & Ziegler: Starke Entwicklung beim Kursziel der Aktie
05.09.2019 - Eckert + Ziegler: Das ist mal ein Statement…
30.08.2019 - Eckert & Ziegler trennt sich von Teilen ihrer Aktivitäten
17.08.2019 - Eckert & Ziegler Aktie: Der faire Wert steigt
13.08.2019 - Eckert & Ziegler: Gewinn deutlich gesteigert